Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for Zambon Switzerland

    Client Virtual Booth

    ZAMBON SWITZERLAND

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    Zambon Switzerland
    Switzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Via Industria, 13 CH-6814 - Cadempino
    Telephone
    Telephone
    +41 919604111
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.zambon.com/en
    Linkedin
    Linkedin
    https://www.linkedin.com/company/zambon
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Zambon to Attend the CHEST Annual Meeting 2022
    Zambon to Attend the CHEST Annual Meeting 2022

    https://www.prnewswire.com/news-releases/zambon-to-attend-the-chest-annual-meeting-2022-301649239.html

    PR NEWSWIRE
    14 Oct 2022
    Share Share
    Luye Grants Zambon Commercialization Rights to Alzheimer's Disease Treatment
    Luye Grants Zambon Commercialization Rights to Alzheimer's Disease Treatment

    https://www.firstwordpharma.com/node/1878805?tsid=4

    FIRSTWORDPHARMA
    11 Nov 2021
    Share Share
    Newron Pharmaceuticals S.p.A. Announces Change in the Board of Directors
    Newron Pharmaceuticals S.p.A. Announces Change in the Board of Directors

    https://www.businesswire.com/news/home/20180208006174/en/Newron-Pharmaceuticals-S.p.A.-Announces-Change-Board-Directors

    BUSINESSWIRE
    18 Feb 2018
    Share Share
    Zambon's Xadago (Safinamide Methanesulfonate) Approved in Europe For Parkinson’s Disease
    Zambon's Xadago (Safinamide Methanesulfonate) Approved in Europe For Parkinson’s Disease

    http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/002396/WC500184968.pdf

    Press Release EMA
    31 Mar 2015
    Share Share
    Zambon’s Xadago (Safinamide) Approved In Europe For Mid-Late Stage PD Patients
    Zambon’s Xadago (Safinamide) Approved In Europe For Mid-Late Stage PD Patients

    http://www.zambongroup.com/en/zc-zcomunicat/zc-zcnews/entry/0/221/2809/parkinsons-disease-pd-eu-commission-approves-xadago-safinamide.html

    BIOSPACE
    26 Feb 2015
    Share Share
    Safinamide New Drug Application (NDA) Re-submitted to the US Food and Drug Administration (FDA)
    Safinamide New Drug Application (NDA) Re-submitted to the US Food and Drug Administration (FDA)

    http://file:///C:/Users/hp/Downloads/PRESS_RELEASE_NEWRON_ZAMBON_FDA_REFILING_DEC_29_EN.PDF.PDF

    Press Release NEWRON PHARMACEUTICALS
    29 Dec 2014
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search